BIRC5 and AL amyloidosis: These data in conjunction with the fact that PLC5 and SNU475 used for our in vitro studies are both TP53 mutants suggests that MAGEA3 may regulate apoptosis in a TP53-independent manner through the stabilization of Survivin similar to what has been described in multiple myeloma [23].